← Back to Search

Procedure

Chiropractic Care for Abdominal Obesity (OBE Trial)

N/A
Recruiting
Led By Tyson Perez, DC, PhD
Research Sponsored by Life University
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Able to walk unassisted on a treadmill
Waist circumference at least 35 inches if female or 40 inches if male
Must not have
Known disorder resulting in syncope/fainting during postural changes (e.g., POTS, orthostatic hypotension)
Diagnosed with rheumatoid arthritis, osteoporosis, or cervical spine instability
Timeline
Screening 3 weeks
Treatment Varies
Follow Up up to 6 months
Awards & highlights
No Placebo-Only Group

Summary

This trial aims to investigate the impact of chiropractic care on psychological, cognitive, and immune-related outcomes in people with high levels of abdominal fat. The prevalence of obesity has increased worldwide, and it is

Who is the study for?
This trial is for individuals with high central adiposity, which means they carry excess fat in the abdominal area. The study aims to include people who are likely experiencing related health issues like stress, cognitive problems, and immune system irregularities.
What is being tested?
The trial is exploring whether chiropractic care can improve health outcomes related to psychoneuroimmunology (PNI) in those with abdominal obesity. This includes looking at stress levels, brain function, nervous system balance, and immune response.
What are the potential side effects?
Chiropractic interventions typically have minimal side effects but may include temporary discomfort or soreness at the site of adjustment. Rarely, some patients might experience fatigue or headache post-treatment.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
I can walk by myself on a treadmill.
Select...
My waist is at least 35 inches (if female) or 40 inches (if male).
Select...
I am between 18 and 65 years old.

Exclusion Criteria

You may be eligible for the trial if you check “No” for criteria below:
Select...
I have a condition that causes me to faint when I stand up.
Select...
I have been diagnosed with rheumatoid arthritis, osteoporosis, or cervical spine instability.
Select...
My chronic pain is more than mild.
Select...
I have a pacemaker or a severe heart condition affecting my heart's function.
Select...
I am taking short-acting benzodiazepines like midazolam or triazolam.
Select...
I have a condition in my mouth or gums that causes easy bleeding.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~up to 6 months
This trial's timeline: 3 weeks for screening, Varies for treatment, and up to 6 months for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
Acceptability
Adherence
Compliance
+6 more
Secondary study objectives
COMPASS-31
Cognitive Flexibility
Gait
+6 more

Awards & Highlights

No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.

Trial Design

1Treatment groups
Experimental Treatment
Group I: Chiropractic careExperimental Treatment1 Intervention
6 weeks of chiropractic care
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Chiropractic
2018
Completed Phase 2
~900

Find a Location

Who is running the clinical trial?

Life UniversityLead Sponsor
19 Previous Clinical Trials
399 Total Patients Enrolled
University of GeorgiaOTHER
107 Previous Clinical Trials
45,475 Total Patients Enrolled
Tyson Perez, DC, PhDPrincipal InvestigatorLife University
2 Previous Clinical Trials
40 Total Patients Enrolled
Tyson Perez, PhDPrincipal InvestigatorLife University
2 Previous Clinical Trials
37 Total Patients Enrolled
~0 spots leftby Jan 2025